Worldwide Distribution - US Nationwide Distributed domestically to AL, AR, AZ, CA, CO, CT, DC, DE, FL, GA, HI, IA, ID, IL, IN, KS, KY, LA, MA, MD, ME, MI, MN, MO, MS, NC, ND, NE, NH, NJ, NM, NV, NY, OH, OK, OR, PA, RI, SC, SD, TN, TX, UT, VA, WA, WI, WV. Distributed internationally to Canada
제품 설명
Innova Self-Expanding Stent System, 180mm. Labeled with Material Number and description as follows: || Product Usage: || The Innova Vascular Self-Expanding Stent System is indicated to improve luminal diameter in the treatment of symptomatic de-novo or restenotic lesions in the native superficial femoral artery (SFA) and/or proximal popliteal artery (PPA) with reference vessel diameters from 4.0 mm to 7.0 mm and lesion lengths up to 190 mm. || a. H74939180051870 (Material Description Innova-EU 5 x 180 x 75); || b. H74939180061870 (Material Description Innova-EU 6 x 180 x 75); || c. H74939180071870 (Material Description Innova-EU 7 x 180 x 75); || d. H74939180071870 (Material Description Innova-EU 8 x 180 x 75); || e. H74939181051830 (Material Description Innova-EU 5 x 180 x 130); || f. H74939181061830 (Material Description Innova-EU 6 x 180 x 130); || g. H74939181071830 (Material Description Innova-EU 7 x 180 x 130); || h. H74939181081830 (Material Description Innova-EU 8 x 180 x 130); || i. H74939259051830 (Material Description Innova-China 5 x 180 x 130); || j. H74939259061830 (Material Description Innova-China 6 x 180 x 130); || k. H74939259071830 (Material Description Innova-China 7 x 180 x 130); || l. H74939259081830 (Material Description Innova-China 8 x 180 x 130); || m. H74939259081870 (Material Description Innova-China 8 x 180 x 75); || n.H74939293051830 (Material Description Innova 5 x 180 x 130); || o. H74939293051870 (Material Description Innova 5 x 180 x 75); || p. H74939293061830 (Material Description Innova 6 x 180 x 130); || q. H74939293061870 (Material Description Innova 6 x 180 x 75); || r. H74939293071830 (Material Description Innova 7 x 180 x 130); || s. H74939293071870 (Material Description Innova 7 x 180 x 75); || t. H74939293081830 (Material Description Innova 8 x 180 x 130); || u. H74939293081870 (Material Description Innova 8 x 180 x 75);
“We take a patient-first approach to assessing the applicability of every recall and communicate to regulatory bodies in all geographies where the recalled device is sold,” Boston Scientific said in a statement to ICIJ. “We have coordinated several recalls across many countries in a timely manner,” the company said, adding that it complies with all national laws, which can often vary and require different processes for reporting information or taking action on recalls. The company said it uses a rigorous and uniform process to take action on recalls and that “when we initiate a field action (e.g. recall, safety alert), every customer who has received an affected product receives a communication that includes a letter for the physician.”